Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$93,214,076
+$12,686,159 QoQ
Shares Held
553,068
-9.5% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#33
of 768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,214,076 | 553,068 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $80,527,917 | 611,264 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $75,561,205 | 532,759 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $89,136,383 | 634,965 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $88,425,551 | 703,521 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $64,084,844 | 579,429 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $83,119,625 | 608,935 | Shares | Defined | 2025-02-12 | |
| 2024-06-30 | $111,299,309 | 808,450 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $109,484,341 | 793,825 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $101,759,563 | 772,310 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $86,195,924 | 766,186 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $68,673,973 | 728,250 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $71,911,140 | 710,444 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $82,864,126 | 693,772 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $111,757,878 | 1,052,235 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $115,129,240 | 1,181,055 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $104,600,811 | 1,115,742 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $82,088,632 | 963,821 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $92,459,540 | 964,024 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $93,673,808 | 962,534 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $87,997,051 | 904,854 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $85,773,288 | 894,870 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $147,140,183 | 1,530,160 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $177,178,404 | 1,452,282 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $145,203,290 | 1,677,681 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||